Marina Biotech, Inc., a commercial stage pharmaceutical company focused on therapeutics for hypertension, arthritis and pain, has changed its name to Adhera Therapeutics, Inc., effective October 9, 2018. The new name aims to reflect the company’s mission to develop and commercialize unique pharmaceutical therapies and leverage technology to improve patient outcomes. “Many treatment regimens fail or have limited impact because of a lack of patient adherence which hinders the benefits of ...